UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 856

Sortiert nach

Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era

Journal of neurology, neurosurgery and psychiatry, 2019-05, Vol.90 (5), p.543

2019

Volltextzugriff (PDF)

Resistance to extinction and behavioral momentum

Behavioural processes, 2012-05, Vol.90 (1), p.89-97

Nevin, John A.

2012

Volltextzugriff (PDF)

BEHAVIORAL MOMENTUM THEORY: EQUATIONS AND APPLICATIONS

Journal of applied behavior analysis, 2011-12, Vol.44 (4), p.877-895

2011

Volltextzugriff (PDF)

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Lancet neurology, 2020-03, Vol.19 (3), p.214-225

2020

Volltextzugriff (PDF)

Quantitative models of persistence and relapse from the perspective of behavioral momentum theory: Fits and misfits

Behavioural processes, 2017-08, Vol.141 (Pt 1), p.92-99

2017

Volltextzugriff (PDF)

Explicating Hearing the Voice of the Customer as a Manifestation of Customer Focus and Assessing its Consequences

The Journal of product innovation management, 2012-11, Vol.29 (6), p.1012-1030

2012

Volltextzugriff (PDF)

The basis of behavioral momentum in the nonlinearity of strength

Journal of the experimental analysis of behavior, 2018-01, Vol.109 (1), p.4-32

2018

Volltextzugriff (PDF)

Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments

Journal of magnetic resonance imaging, 2024-06, Vol.59 (6), p.2192-2201

2024

Volltextzugriff (PDF)

Comparing positive and negative reinforcement: A fantasy experiment

Journal of the experimental analysis of behavior, 2017-01, Vol.107 (1), p.34-38

2017

Volltextzugriff (PDF)

MS-SMART study: systematic sampling bias concerns – Authors' reply

Lancet neurology, 2020-06, Vol.19 (6), p.479-480

2020

Volltextzugriff (PDF)

Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm

Journal of the neurological sciences, 2019-12, Vol.407, p.116456-116456, Article 116456

2019

Volltextzugriff (PDF)

Mapping topography and network of brain injury in patients with disorders of consciousness

Frontiers in neurology, 2023-03, Vol.14, p.1027160-1027160

2023

Volltextzugriff (PDF)

AN EVALUATION OF PERSISTENCE OF TREATMENT EFFECTS DURING LONG-TERM TREATMENT OF DESTRUCTIVE BEHAVIOR

Journal of the experimental analysis of behavior, 2011-09, Vol.96 (2), p.261-282

2011

Volltextzugriff (PDF)

Intravitreal anti-vascular endothelial growth factor therapy in the treatment of vision loss associated with hematologic malignancy

American journal of ophthalmology case reports, 2024-12, Vol.36, p.102095, Article 102095

2024

Volltextzugriff (PDF)

Behavioral momentum and the Law of Effect

The Behavioral and brain sciences, 2000-02, Vol.23 (1), p.73-90, Article S0140525X00002405

2000

Volltextzugriff (PDF)

Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials

Trials, 2022-08, Vol.23 (1), p.644-644, Article 644

2022

Volltextzugriff (PDF)

Maintenance, Generalization, and Treatment Relapse: A Behavioral Momentum Analysis

Education & treatment of children, 2017-02, Vol.40 (1), p.27-42

2017

Volltextzugriff (PDF)

The Role of Contingencies and Stimuli in a Human Laboratory Model of Treatment of Problem Behavior

The Psychological record, 2017-12, Vol.67 (4), p.463-471

2017

Volltextzugriff (PDF)

Variation, Selection, and Social Action

Behavior and social issues, 2018-01, Vol.27 (1), p.AA1-AA3

Nevin, John A. Tony

2018

Volltextzugriff (PDF)

3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis

BMJ neurology open, 2024-08, Vol.6 (Suppl 1), p.A2-A2

2024

Volltextzugriff (PDF)

3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

BMJ neurology open, 2024-08, Vol.6 (Suppl 1), p.A43-A43

2024

Volltextzugriff (PDF)

Fairness-Trust-Loyalty Relationship Under Varying Conditions of Supplier-Buyer Interdependence

Journal of marketing theory and practice, 2011-01, Vol.19 (1), p.39-56

2011

Volltextzugriff (PDF)

Delivering alternative reinforcement in a distinct context reduces its counter‐therapeutic effects on relapse

Journal of the experimental analysis of behavior, 2018-05, Vol.109 (3), p.492-505

2018

Volltextzugriff (PDF)

Comment on Gallistel: Behavior theory and information theory: Some parallels

Behavioural processes, 2012-05, Vol.90 (1), p.84-86

Nevin, John A

2012

Volltextzugriff (PDF)

1 – 25 von 856

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(467)
Mit Volltextzugriff
(538)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era

Resistance to extinction and behavioral momentum

BEHAVIORAL MOMENTUM THEORY: EQUATIONS AND APPLICATIONS

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Quantitative models of persistence and relapse from the perspective of behavioral momentum theory: Fits and misfits

Explicating Hearing the Voice of the Customer as a Manifestation of Customer Focus and Assessing its Consequences

The basis of behavioral momentum in the nonlinearity of strength

Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments

Comparing positive and negative reinforcement: A fantasy experiment

MS-SMART study: systematic sampling bias concerns – Authors' reply

Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm

Mapping topography and network of brain injury in patients with disorders of consciousness

AN EVALUATION OF PERSISTENCE OF TREATMENT EFFECTS DURING LONG-TERM TREATMENT OF DESTRUCTIVE BEHAVIOR

Intravitreal anti-vascular endothelial growth factor therapy in the treatment of vision loss associated with hematologic malignancy

Behavioral momentum and the Law of Effect

Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials

Maintenance, Generalization, and Treatment Relapse: A Behavioral Momentum Analysis

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

The Role of Contingencies and Stimuli in a Human Laboratory Model of Treatment of Problem Behavior

Variation, Selection, and Social Action

3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis

3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Fairness-Trust-Loyalty Relationship Under Varying Conditions of Supplier-Buyer Interdependence

Delivering alternative reinforcement in a distinct context reduces its counter‐therapeutic effects on relapse

Comment on Gallistel: Behavior theory and information theory: Some parallels

Suchergebnisse filtern